54 /100
HIGH RISK
Score updated May 30, 2026

BTAI — BioXcel Therapeutics, Inc. Dilution Risk Tracker

Track BTAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BTAI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
40%
🔄 Reverse Split 40%
• 50-day avg $1.20 approaching $1 threshold
• 6 months cash with weak price
📜 Warrant Exercise 40%
• Significant warrants: 28% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration 40%
• Score rose 35 points recently (worsening)
🔔 Track BTAI — Get forecast alerts →

💹 Market Data

Market Cap$36.13M
Shares Outstanding30.88M
Float26.40M
Cash$17.18M
Debt$100.29M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 50.7% shares (2025Q4 vs prior)
45 institutional holders · 3.55M shares
#1 MILLENNIUM MANAGEMENT LLC 1.84M shares
#2 VANGUARD GROUP INC 292.8K shares
#3 OAKTREE CAPITAL MANAGEMENT LP 241.2K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.56M
Days to Cover5.7
% of Float13.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BTAI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BTAI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BTAI
📊 BTAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BTAI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 BTAI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.